PLAS-FREE News
5 articles
growth-positive
טכנולוגיה שנועדה להציל חיים - כחול לבן Plas-Free
Plas-Free, a company founded by Dr. Zeev Dvashi and Prof. Abed Alraouf Higazi, has developed a patented technology to improve blood products by removing specific clot-dissolving substances, enhancing clot stability, and reducing bleeding. The technology is applicable in various medical scenarios, including surgeries and injuries. Since its inception in 2017, Plas-Free has secured patents in multiple countries, including the US, Europe, and China. The company received support from the NGT Incubator and collaborated with IP experts from Reinhold Cohn Group to build a robust intellectual property strategy. The article highlights the importance of early-stage strategy development and patentability for attracting investors and achieving financial success.
InvestmentPartners
PLAS-FREE re-citification of ISO13485
This certificate is proudly presented in recognition and appreciation for your startup
competition presentation at ENRICH Funding Summit post JP Morgan Healthcare
Conference 2022.
Nazareth biotech firm Plas-Free wins 2nd place at BIO Digital 2021
A new way to treat massive-bleeding patients ClearPlasma Project Results in brief H2020 CORDIS European Commission